SCHEMBL18052960

SCHEMBL18052960

CCCOC(=O)n1ccc2c(F)c(O)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ APP P05067 1/20 0.35
▸ ELANE P08246 2/20 0.33
▸ NOTUM Q6P988 1/20 0.33
▸ LMNA P02545 2/20 0.33
▸ KMT2A Q03164 1/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ JMJD6 Q6NYC1 1/20 0.31
▸ LPO P22079 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ STS P08842 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20977770 0.84 KDM4E (0.36) KDM4EPOLBALDH1A1ELANEKMT2A
SCHEMBL18054133 0.83 ELANE (0.34) KDM4EPOLBALDH1A1TSHRELANE
SCHEMBL20224070 0.81 ELANE (0.33) ALDH1A1ELANENOTUMKMT2A
SCHEMBL18053010 0.79 KDM4E (0.34) KDM4EPOLBALDH1A1ESR1CHRM1
SCHEMBL18052980 0.76 NOTUM (0.54) KDM4EPOLBALDH1A1ESR1NOTUM
SCHEMBL20224079 0.74 ALDH1A1 (0.30) ALDH1A1
SCHEMBL18052970 0.74 ALDH1A1 (0.39) KDM4EPOLBALDH1A1TSHRELANE
SCHEMBL18054331 0.74 NPSR1 (0.39) KDM4EPOLBALDH1A1TSHRELANE
SCHEMBL13003012 0.73 BCHE (0.45) KDM4EALDH1A1ESR1TSHRTDP1
SCHEMBL20224081 0.72 NOTUM (0.41) ALDH1A1ELANENOTUMLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016138527-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. (US) 2016-09-01 — — WO disclosed
Send feedback